Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-26-000600·Centessa Pharmaceuticals plc
Schedule 13G ownership disclosure
CENTESSA PHARMACEUTICALS PLC
COMMON STOCK · CUSIP: 152309100
Event date: 2026-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 10,999,793.00 · Class: 12.2%
- Abigail P. Johnson
Shares: 10,999,793.00 · Class: 12.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-000600
- Form type
- SCHEDULE 13G/A
- Filer
- Centessa Pharmaceuticals plc
- CIK
- CIK 1847903
- Filed
- Feb 06, 2026
- Reporting period
- Jan 30, 2026
- Description
- Schedule 13G beneficial ownership